| Identification | Back Directory | [Name]
3β,7β,23-Trihydroxycucurbita-5,24-dien-19-al | [CAS]
91590-76-0 | [Synonyms]
Momordicin I
Momordicine I
(+)-Momordicin I
Momordicine II aglycone
Kuguaglycoside G aglycon
3β,7β,23-Trihydroxycucurbita-5,24-dien-19-al
(10α)-3β,7β,23-Trihydroxy-19-norlanosta-5,24-diene-9β-carbaldehyde
19-Norlanosta-5,24-diene-9-carboxaldehyde, 3,7,23-trihydroxy-, (3β,7β,9β,10α,24R)- | [Molecular Formula]
C30H48O4 | [MDL Number]
MFCD27664990 | [MOL File]
91590-76-0.mol | [Molecular Weight]
472.7 |
| Chemical Properties | Back Directory | [Boiling point ]
592.4±50.0 °C(Predicted) | [density ]
1.11±0.1 g/cm3(Predicted) | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [pka]
13.73±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Momordicine I, a triterpenoid compound extracted from momordica charantia L. Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-ζ[1]. | [References]
[1] Li H, et al. Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-ζ. Korean J Physiol Pharmacol. 2023 Jan 1;27(1):75-84. DOI:10.4196/kjpp.2023.27.1.75 |
|
|